相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The immune system in atherosclerosis
Goran K. Hansson et al.
NATURE IMMUNOLOGY (2011)
Clinical studies on the management of periodontal diseases utilizing subantimicrobial dose doxycycline (SDD)
Jack Caton et al.
PHARMACOLOGICAL RESEARCH (2011)
Doxycycline 40 mg Capsules (30 mg Immediate-Release/10 mg Delayed-Release Beads) Anti-Inflammatory Dose in Rosacea
Kate McKeage et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2010)
Pharmacological modulation of vascular inflammation in atherothrombosis
Raffaele De Caterina et al.
INNATE INFLAMMATION AND STROKE (2010)
The natural history of aortic atherosclerosis: A systematic histopathological evaluation of the peri-renal region
R. A. van Dijk et al.
ATHEROSCLEROSIS (2010)
Nitroglycerin-mediated vasodilatation of the brachial artery may predict long-term cardiovascular events irrespective of the presence of atherosclerotic disease
Daijirou Akamatsu et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2010)
Clinical Trial of Doxycycline for Matrix Metalloproteinase-9 Inhibition in Patients With an Abdominal Aneurysm Doxycycline Selectively Depletes Aortic Wall Neutrophils and Cytotoxic T Cells
Jan H. N. Lindeman et al.
CIRCULATION (2009)
c-Jun N-Terminal Kinase 2 Deficiency Protects Against Hypercholesterolemia-Induced Endothelial Dysfunction and Oxidative Stress
Elena Osto et al.
CIRCULATION (2008)
Enhanced expression and activation of pro-inflammatory transcription factors distinguish aneurysmal from atherosclerotic aorta: IL-6- and IL-8-dominated inflammatory responses prevail in the human aneurysm
Jan H. N. Lindeman et al.
CLINICAL SCIENCE (2008)
MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets
Anthony J. Muslin
CLINICAL SCIENCE (2008)
Periodontal diseases and rheumatoid arthritis: A coincident model for therapeutic intervention?
Mena Soory
CURRENT DRUG METABOLISM (2007)
Human visceral adipose tissue and the plasminogen activator inhibitor type 1
J. H. N. Lindeman et al.
INTERNATIONAL JOURNAL OF OBESITY (2007)
Long-term follow-up of the West of Scotland Coronary Prevention Study
Ian Ford et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Early effects on endothelial function of Atorvastatin 40 mg twice daily and its withdrawal
E Taneva et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Protective effect of doxycycline use on coronary artery disease?
M Kardara et al.
JOURNAL OF INFECTION (2006)
Tetracyclines: Nonantibiotic properties and their clinical implications
AN Sapadin et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Heat shock treatment suppresses angiotensin II-induced SP-1 and AP-1 and stimulates Oct-1 DNA-binding activity in heart
Y Chen et al.
INFLAMMATION RESEARCH (2005)
Doxycycline inhibits TGF-β1-induced MMP-9 via Smad and MAPK pathways in human corneal epithelial cells
HS Kim et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
Safety of doxycycline and minocycline: A systematic review
K Smith et al.
CLINICAL THERAPEUTICS (2005)
Leptin and the proinflammatory state associated with human obesity
CJ Hukshorn et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Endothelial dysfunction in peripheral arterial disease is related to increase in plasma markers of inflammation and severity of peripheral circulatory impairment but not to classic risk factors and atherosclerotic burden
G Brevetti et al.
JOURNAL OF VASCULAR SURGERY (2003)
Detection of endothelial dysfunction with brachial artery ultrasound scanning
MD Faulx et al.
AMERICAN HEART JOURNAL (2003)
Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease
N Gokce et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms
MW Manning et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Prospective, randomized, double-blind trial investigating the effect of doxycycline on matrix metalloproteinase expression within atherosclerotic carotid plaques
B Axisa et al.
STROKE (2002)
Doxycycline modulates smooth muscle cell growth, migration, and matrix remodeling after arterial injury
MP Bendeck et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Losartan, an angiotensin type I receptor antagonist, improves conduit vessel endothelial function in Type II diabetes
C Cheetham et al.
CLINICAL SCIENCE (2001)
Increased expression and activation of stress-activated protein kinases/c-jun NH2-terminal protein kinases in atherosclerotic lesions coincide with p53
B Metzler et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Lessons from sudden coronary death - A comprehensive morphological classification scheme for atherosclerotic lesions
R Virmani et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Age-dependent increase in c-fos activity and cyclin A expression in vascular smooth muscle cells - A potential link between aging, smooth muscle cell proliferation and atherosclerosis
A Rivard et al.
CARDIOVASCULAR RESEARCH (2000)
分享论文
